Overview of the Malaysian Pharma Industry Market Size and Growth Trends The Malaysian pharmaceutical market is poised for continued growth, driven by a confluence of demographic, economic, and health-related factors. As of 2024, the market is projected to reach a valuation of approximately US$1,702.00 million. This robust growth trajectory is indicative of several underlying trends and drivers. One of the most significant segments within the Malaysian pharmaceutical market is oncology drugs. This segment alone is expected to command a market